1645113 - Novocure Ltd - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - NVCR (1645113)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
86 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P3+5-12+4-55
S18-1-2-15-24

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-13
NVCRPalti YoramCTOS - Sale$17.13-30,0001,431,054-2%-$513,870
M
2017-11-08
NVCRPalti YoramCTOS - Sale$18.49-90,0001,461,054-6%-$1,663,832
M
2017-11-06
NVCRPalti YoramCTOS - Sale$21.06-60,0001,551,054-4%-$1,263,760
2017-11-06
NVCRKirson Eilon D.Chief Science OfficerS - Sale$22.00-9,10028,501-24%-$200,200
2017-11-06
NVCRDanziger AsafCEOS - Sale$22.00-6,919749,105-1%-$152,218
M
2017-11-02
NVCRPalti YoramCTOS - Sale$21.72-60,0001,611,054-4%-$1,303,200
M
2017-11-02
NVCRKirson Eilon D.Chief Science OfficerS - Sale$22.00-3,40037,601-8%-$74,800
M
2017-11-02
NVCRAmbrogi Michael J.COOS - Sale$22.00-1,20024,087-5%-$26,400
2017-11-03
NVCRDanziger AsafCEOS - Sale$22.00-2,300756,0240%-$50,600
M
2017-10-31
NVCRKirson Eilon D.Chief Science OfficerS - Sale$22.01-22,26941,001-35%-$490,110
M
2017-10-31
NVCRDanziger AsafCEOS - Sale$22.01-15,866758,324-2%-$349,170
M
2017-10-31
NVCRAmbrogi Michael J.COOS - Sale$22.01-24,32725,287-49%-$535,364
2017-09-25
NVCRKirson Eilon D.Chief Science OfficerD - Sale to issuer$22.03-1,90063,270-3%-$41,865
2017-09-25
NVCRDanziger AsafCEOS - Sale$22.05-900774,1900%-$19,845
2017-09-25
NVCRAmbrogi Michael J.COOD - Sale to issuer$22.05-3,20049,614-6%-$70,555
2017-09-19
NVCRAmbrogi Michael J.COOD - Sale to issuer$22.00-3,20052,814-6%-$70,400
M
2017-09-13
NVCRKirson Eilon D.Chief Science OfficerD - Sale to issuer$22.01-49,37265,170-43%-$1,086,845
M
2017-09-13
NVCRDanziger AsafCEOS - Sale$22.01-37,272775,090-5%-$820,502
M
2017-09-13
NVCRAmbrogi Michael J.COOD - Sale to issuer$22.02-78,07356,014-58%-$1,718,939
D
2017-07-14
NVCRDanziger AsafCEOM - OptEx$0.38+354,780812,362+78%+$134,816
2017-07-11
NVCRDanziger AsafCEOS - Sale$19.95-7,383457,582-2%-$147,325
M
2017-07-07
NVCRDanziger AsafCEOS - Sale$18.07-274,359464,965-37%-$4,956,558
2017-07-05
NVCRLongsworth Todd ChristopherGCA - Grant$6.67+2,8104,832+139%+$18,751
2017-07-05
NVCRGroenhuysen Wilhelmus CmCFOA - Grant$6.67+2,484268,768+1%+$16,576
2017-07-05
NVCRAmbrogi Michael J.COOA - Grant$6.67+1,395134,087+1%+$9,309
2017-07-05
NVCRKirson Eilon D.Chief Science OfficerA - Grant$6.67+3,181114,542+3%+$21,227
2017-07-05
NVCRKirson Eilon D.Chief Science OfficerD - Sale to issuer$18.14-111,361114,542-49%-$2,020,534
2017-07-05
NVCRDanziger AsafCEOA - Grant$6.67+2,545739,3240%+$16,983
M
2017-07-05
NVCRDanziger AsafCEOS - Sale$18.14-160,138739,324-18%-$2,905,261
M
2017-06-23
NVCRPomona Capital Vii, L.P.10%S - Sale$17.35-1,072,5322,741,925-28%-$18,607,080
2017-06-21
NVCRKirson Eilon D.Chief Science OfficerS - Sale$16.77-66,361222,722-23%-$1,113,206
2017-06-19
NVCRKirson Eilon D.Chief Science OfficerS - Sale$15.06-15,000289,083-5%-$225,885
2017-06-19
NVCRDanziger AsafCEOS - Sale$15.51-124,720896,917-12%-$1,934,906
M
2017-06-15
NVCRDanziger AsafCEOS - Sale$15.15-42,4571,021,637-4%-$643,238
2017-06-13
NVCRKirson Eilon D.Chief Science OfficerS - Sale$15.01-9,044304,083-3%-$135,769
D
2017-06-14
NVCRDoyle William FDirM - OptEx$3.59+6,49891,197+8%+$23,328
M
2017-06-13
NVCRDanziger AsafCEOS - Sale$15.22-94,1021,064,094-8%-$1,432,146
M
2017-06-09
NVCRDanziger AsafCEOS - Sale$15.13-180,6011,158,196-13%-$2,731,913
M
2017-06-09
NVCRKirson Eilon D.Chief Science OfficerS - Sale$15.03-20,956313,127-6%-$315,053
2017-06-05
NVCRPalti YoramCTOS - Sale$13.81-3,8250-100%-$52,842
M
2017-06-01
NVCRPalti YoramCTOS - Sale$13.27-8,0003,825-68%-$106,140
M
2017-05-30
NVCRPalti YoramCTOS - Sale$12.49-8,00011,825-40%-$99,896
M
2017-05-25
NVCRPalti YoramCTOS - Sale$12.88-8,00019,825-29%-$103,004
2017-05-24
NVCRPalti YoramCTOS - Sale$13.15-4,00027,825-13%-$52,612
M
2017-05-22
NVCRPalti YoramCTOS - Sale$11.73-8,00031,825-20%-$93,876
M
2017-05-18
NVCRPalti YoramCTOS - Sale$11.39-8,00039,825-17%-$91,100
2017-05-17
NVCRPalti YoramCTOS - Sale$11.47-4,00047,825-8%-$45,884
M
2017-05-15
NVCRPalti YoramCTOS - Sale$12.04-8,00051,825-13%-$96,360
M
2017-05-09
NVCRPalti YoramCTOS - Sale$12.29-8,00067,825-11%-$98,3000
M
2017-05-05
NVCRPalti YoramCTOS - Sale$11.82-8,00075,825-10%-$94,576+1
M
2017-05-03
NVCRPalti YoramCTOS - Sale$11.42-8,00083,825-9%-$91,360+60
M
2017-05-01
NVCRPalti YoramCTOS - Sale$11.64-8,00091,825-8%-$93,1200+7
M
2017-04-27
NVCRPalti YoramCTOS - Sale$11.25-8,00099,825-7%-$89,980+10
M
2017-04-25
NVCRPalti YoramCTOS - Sale$10.78-8,000107,825-7%-$86,26400
M
2017-04-21
NVCRPalti YoramCTOS - Sale$11.26-8,000115,825-6%-$90,048+1+9
M
2017-04-19
NVCRPalti YoramCTOS - Sale$11.24-8,000123,825-6%-$89,952-7-1
M
2017-04-12
NVCRPalti YoramCTOS - Sale$10.64-16,000131,825-11%-$170,220+4-3
2017-03-14
NVCRPerlhagen Gert L.DirP - Purchase$6.93+125,0006,125,000+2%+$866,250+6-3+46
D
2017-02-28
NVCRDoyle William FExec COB, 10%F - Tax$7.60-572,72519,860,466-3%-$4,352,710-5-14-1
D
2017-02-28
NVCRDoyle William FExec COB, 10%M - OptEx$3.59+1,212,45419,860,466+7%+$4,352,710-5-14-1
2017-01-06
NVCRAmbrogi Michael J.COOA - Grant$6.67+1,108132,692+1%+$7,3940-11-12
2017-01-06
NVCRMelnyk Peter M.Chief Commercial OfficerA - Grant$6.67+2,4032,403New+$16,0350-11-12
2017-01-06
NVCRGroenhuysen Wilhelmus CmCFOA - Grant$6.67+3,156266,284+1%+$21,0600-11-12
2017-01-06
NVCRDanziger AsafCEOA - Grant$6.67+3,156995,8430%+$21,0600-11-12
M
2016-12-21
NVCRAmbrogi Michael J.COOS - Sale$8.27-27,500131,584-17%-$227,303-2-6-22
M
2016-12-19
NVCRAmbrogi Michael J.COOS - Sale$8.69-40,000159,084-20%-$347,654-1-4-21
M
2016-12-15
NVCRAmbrogi Michael J.COOS - Sale$8.93-40,000199,084-17%-$357,128-1-9-25
M
2016-12-13
NVCRAmbrogi Michael J.COOS - Sale$8.97-40,000239,084-14%-$358,982-6-9-27
M
2016-12-09
NVCRAmbrogi Michael J.COOS - Sale$9.01-15,000279,084-5%-$135,110+2-2-21
M
2016-12-07
NVCRAmbrogi Michael J.COOS - Sale$8.30-10,000294,084-3%-$83,007-10-10
M
2016-12-05
NVCRAmbrogi Michael J.COOS - Sale$8.24-10,000304,084-3%-$82,355+5+8-4
D
2016-12-05
NVCRKirson Eilon D.Chief Scientific OfficerM - OptEx$0.17+156,073334,083+88%+$26,5320+7-4
2016-08-05
NVCRPerlhagen Gert L.Dir, 10%S - Sale$1.85-676,5760-100%-$1,252,031-2-3+4-9
2016-06-08
NVCRAmbrogi Michael J.COOS - Sale$12.24-20,000314,084-6%-$244,800-19-16-13-38
D
2016-04-18
NVCRPalti YoramCTOM - OptEx$0.17+147,8251,818,879+9%+$25,130-1+14-8-41
D
2016-05-13
NVCRVernon W AnthonyDirM - OptEx$0.17+249,085249,085New+$42,344-2-3-10-25
D
2016-05-06
NVCRDoyle William FDir, 10%F - Tax$12.59-243,35721,463,401-1%-$3,063,8650-6-5-49
D
2016-05-06
NVCRDoyle William FDir, 10%M - OptEx$3.59+853,44021,463,401+4%+$3,063,8500-6-5-49
D
2016-05-06
NVCRPerlhagen Gert L.Dir, 10%M - OptEx$3.59+207,3867,893,365+3%+$744,5160-6-5-49
D
2016-05-05
NVCRLangloss Timothy J.DirM - OptEx$3.59+3,34035,548+10%+$11,9910-5-9-49
D
2016-04-18
NVCRKirson Eilon D.Chief Scientific OfficerM - OptEx$0.17+29,565178,010+20%+$5,026-7-6-16-46
D
2016-04-13
NVCRDanziger AsafCEOM - OptEx$0.17+59,130992,687+6%+$10,052-3-15-25-50
2016-03-03
NVCRDanziger AsafCEOP - Purchase$15.00+10,000933,557+1%+$150,000+5-16-17-55
2016-03-03
NVCRMylod Robert J JrDirP - Purchase$15.78+20,000168,114+14%+$315,600+5-16-17-55
D
2016-01-04
NVCRAmbrogi Michael J.COOM - OptEx$0.17+332,984334,084>999%+$56,607-1-10-52-52
D
2015-12-21
NVCRAmbrogi Michael J.COOM - OptEx$0.17+1,1001,100New+$187-2-14-50-61

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top